Maintenance olaparib following platinum-based chemotherapy in newly diagnosed patients (pts) with advanced ovarian cancer (OC) and a BRCA1/2 mutation (BRCAm): Phase III SOLO1 trial

Michael Friedländer, Paul DiSilvestro, Antonio González-Martı́n et al.|Annals of Oncology|2018

Cited by 2